Ethyl 8-fluoro-1-[2-hydroxy-3-(4-nitroimidazol-1-yl)propyl]-4-oxoquinoline-3-carboxylate
C18H17FN4O6 — CID 118714073
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl 8-fluoro-1-[2-hydroxy-3-(4-nitroimidazol-1-yl)propyl]-4-oxoquinoline-3-carboxylate
Ethyl 8-fluoro-1-[2-hydroxy-3-(4-nitroimidazol-1-yl)propyl]-4-oxoquinoline-3-carboxylate (PubChem CID 118714073) has the molecular formula C18H17FN4O6 and a molecular weight of 404.35 g/mol. Its IUPAC name is ethyl 8-fluoro-1-[2-hydroxy-3-(4-nitroimidazol-1-yl)propyl]-4-oxoquinoline-3-carboxylate.
Molecular Properties
| Compound Name | Ethyl 8-fluoro-1-[2-hydroxy-3-(4-nitroimidazol-1-yl)propyl]-4-oxoquinoline-3-carboxylate |
|---|---|
| PubChem CID | 118714073 |
| Molecular Formula | C18H17FN4O6 |
| Molecular Weight | 404.35 g/mol |
| Exact Mass | 404.11 |
| IUPAC Name | ethyl 8-fluoro-1-[2-hydroxy-3-(4-nitroimidazol-1-yl)propyl]-4-oxoquinoline-3-carboxylate |
| SMILES | CCOC(=O)c1cn(CC(O)Cn2cnc([N+](=O)[O-])c2)c2c(F)cccc2c1=O |
| InChI | InChI=1S/C18H17FN4O6/c1-2-29-18(26)13-8-22(16-12(17(13)25)4-3-5-14(16)19)7-11(24)6-21-9-15(20-10-21)23(27)28/h3-5,8-11,24H,2,6-7H2,1H3 |
| InChIKey | ZRWUHINQZNVKLH-UHFFFAOYSA-N |
| XLogP | 1.48 |
| TPSA | 129.49 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 404.35 |
| LogP ≤ 5 | 1.48 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118714073 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.